Gavin Wood

Insider Reports History

Reporting-owner location: Abingdon, Oxfordshire, United Kingdom
Latest reporting-owner signature: /s/ Gavin Wood
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Gavin Wood

Form 4 holding Chief Financial Officer

Adaptimmune Therapeutics PLC

Security class: Ordinary Shares with a nominal value of GBP0.001 per share
Shares / value: 0
Estimated value: $0
Report date: 02 Sep 2025
Price: $0.0800
Ownership: Direct

Insider Reports Filed by Gavin Wood

4 ADAP

Adaptimmune Therapeutics PLC

Report period: 02 Sep 2025
Transactions: 1
Transaction value: -$950
Accepted by SEC: 03 Sep 2025, 17:00
Role: Chief Financial Officer
Next action: Open filing details

4 ADAP

Adaptimmune Therapeutics PLC

Report period: 15 Jan 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 17 Jan 2024, 17:01
Role: Chief Financial Officer
Next action: Open filing details

4 ADAP

Adaptimmune Therapeutics PLC

Report period: 17 Jan 2023
Transactions: 3
Transaction value: $0
Accepted by SEC: 17 Jan 2023, 20:04
Role: Chief Financial Officer
Next action: Open filing details

4 ADAP

Adaptimmune Therapeutics PLC

Report period: 20 May 2022
Transactions: 1
Transaction value: +$11,326
Accepted by SEC: 23 May 2022, 21:00
Role: Chief Financial Officer
Next action: Open filing details

4 ADAP

Adaptimmune Therapeutics PLC

Report period: 12 Jan 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 13 Jan 2022, 20:03
Role: Chief Financial Officer
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .